Drug Information

Drug General Information
Drug ID
D00LOL
Former ID
DIB019431
Drug Name
compound 3
Drug Type
Small molecular drug
Indication Discovery agent Investigative [532425]
Structure
Download
2D MOL
Formula
C15H13N5O
InChI
InChI=1S/C15H13N5O/c1-10-4-6-11(7-5-10)14(21)20-15(16)18-13(19-20)12-3-2-8-17-9-12/h2-9H,1H3,(H2,16,18,19)
InChIKey
BIEYFOHSWAIQDF-UHFFFAOYSA-N
PubChem Compound ID
970375
PubChem Substance ID
1232520, 3628950, 5666801, 8720204, 14731064, 26122049, 44256837, 49780687, 57782421, 76018910, 89136844, 92170812, 106243976, 110108074, 125016453, 126719771, 160713779, 170131135, 174499905, 179353604, 228661646, 252166696, 252615846
Target and Pathway
Target(s) Suppressor of tumorigenicity 14 Target Info Inhibitor [532425]
kallikrein-related peptidase 5 Target Info Inhibitor [532425]
Kallikrein 7 Target Info Inhibitor [532425]
kallikrein-related peptidase 14 Target Info Inhibitor [532425]
KEGG Pathway MicroRNAs in cancer
NetPath Pathway TCR Signaling Pathway
Reactome Degradation of the extracellular matrix
WikiPathways Hair Follicle Development: Cytodifferentiation (Part 3 of 3)
References
Ref 5324251,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases. Bioorg Med Chem Lett. 2013 Aug 15;23(16):4547-51.
Ref 5324251,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases. Bioorg Med Chem Lett. 2013 Aug 15;23(16):4547-51.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.